Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer
    
Yazarlar (6)
Doç. Dr. Nevin KARAKUŞ Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Nurten Kara Ondokuz Mayis University, Medical School, Türkiye
Ali N. Ulusoy
Ondokuz Mayis University, Medical School, Türkiye
Cihangir Ozaslan Ankara Oncology Education And Research Hospital, Türkiye
Sengul Tural Ondokuz Mayis University, Medical School, Türkiye
Ismail Okan Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Oncology Research and Treatment (Q4)
Dergi ISSN 2296-5270 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 08-2015
Cilt / Sayı / Sayfa 38 / 9 / 418–422 DOI 10.1159/000438940
Özet
Background Polymorphisms of estrogen synthesis-and adiposity-related genes can contribute to the development of breast cancer. The purpose of the current study was to analyze the association between CYP17A1 T27C (rs743572) and LEP-2548G> A (rs7799039) gene polymorphisms and breast cancer. Material and Methods 199 breast cancer patients and 197 healthy controls were included in the study. The CYP17A1 and LEP gene polymorphisms were determined using polymerase chain reaction-based restriction fragment length polymorphism analysis. Results No statistically significant association was found between these polymorphisms and breast cancer risk among a Turkish population. However, stratified analysis of these polymorphisms in relation to different clinicopathological characteristics of breast cancer revealed an association between breast cancer diagnosis and the CYP17A1 T27C …
Anahtar Kelimeler
Breast cancer | CYP17A1 | Genetic susceptibility | Leptin | Polymorphism
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 16
Scopus 2
Web of Science 10
Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer

Paylaş